» Articles » PMID: 11122224

Atopic Dermatitis: Pathogenetic Mechanisms

Overview
Specialty Dermatology
Date 2000 Dec 21
PMID 11122224
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease with increasing incidence and socio-economical relevance. The diagnosis is made on clinical grounds and different diagnostic criteria sets have been established. The majority of all AD cases is associated with a sensitization to environmental allergens and increased serum IgE (so-called extrinsic AD), but about 10--30% of all cases suffer from the so-called intrinsic AD, which obviously lacks any link to the classical atopic diathesis. The genetic background of AD has been investigated by target gene approach by different groups with mostly contradictory results for each of the genes under study. An imbalance in the spectrum of Th1/Th2 responses, a disturbed prostaglandin metabolism, intrinsic defects in keratinocyte function, delayed eosinophil apoptosis, IgE-mediated facilitated antigen presentation by epidermal dendritic cells, a two phase model of the inflammatory response and staphylococcal superantigen effects are among the currently studied pathogenetical aspects of extrinsic AD, which are reviewed in this paper.

Citing Articles

Exposure to Volatile Organic Compounds May Contribute to Atopic Dermatitis in Adults.

Tang K, Chen Y, Lee M, Chen T, Lai C, Lin C Biomedicines. 2024; 12(7).

PMID: 39061993 PMC: 11274632. DOI: 10.3390/biomedicines12071419.


The Promising Role of Polyphenols in Skin Disorders.

Farhan M Molecules. 2024; 29(4).

PMID: 38398617 PMC: 10893284. DOI: 10.3390/molecules29040865.


Chronic Atopic Dermatitis with Eosinophilia Improved by Daesiho-Tang: A Case Report.

Park M, Lee J, Seong E, Lee D, Jo E Clin Cosmet Investig Dermatol. 2023; 16:2561-2572.

PMID: 37750085 PMC: 10518174. DOI: 10.2147/CCID.S424225.


Evaluation of the Efficacy of an Ecobiological Dermo-Cosmetic Product to Help Manage and Prevent Relapses of Eyelid Atopic Dermatitis.

Bergera-Virassamynaik S, Ardiet N, Sayag M Clin Cosmet Investig Dermatol. 2023; 16:677-686.

PMID: 36969386 PMC: 10032143. DOI: 10.2147/CCID.S401576.


L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice.

Kim K, Kim S, Mony T, Bae H, Choi S, Choi Y Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297328 PMC: 9610696. DOI: 10.3390/ph15101217.